.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Argus Health
US Department of Justice
Cerilliant
Deloitte
Cipla
Moodys
Express Scripts
Fish and Richardson

Generated: December 18, 2017

DrugPatentWatch Database Preview

Cholestyramine - Generic Drug Details

« Back to Dashboard

What are the generic sources for cholestyramine and what is the scope of cholestyramine patent protection?

Cholestyramine
is the generic ingredient in eight branded drugs marketed by Parke Davis, Ani Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Teva, Teva Pharms, Zydus Pharms Usa Inc, Upsher-smith Labs, Bristol Myers, and Apothecon, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Seven suppliers are listed for this compound.

Pharmacology for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
TevaCHOLESTYRAMINE LIGHTcholestyraminePOWDER;ORAL074348-002May 28, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva PharmsCHOLESTYRAMINE LIGHTcholestyraminePOWDER;ORAL074555-002Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol MyersQUESTRAN LIGHTcholestyraminePOWDER;ORAL019669-001Dec 5, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe
SandozCHOLESTYRAMINEcholestyraminePOWDER;ORAL074557-002Aug 15, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms IncCHOLESTYRAMINEcholestyraminePOWDER;ORAL074554-001Oct 2, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms IncCHOLESTYRAMINEcholestyraminePOWDER;ORAL074554-002Oct 2, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
SandozCHOLESTYRAMINE LIGHTcholestyraminePOWDER;ORAL074558-001Aug 15, 1996ABRXNoYes► Subscribe► Subscribe► Subscribe
SandozCHOLESTYRAMINE LIGHTcholestyraminePOWDER;ORAL074558-002Aug 15, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith LabsPREVALITEcholestyraminePOWDER;ORAL073263-001Feb 22, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
TevaCHOLESTYRAMINEcholestyraminePOWDER;ORAL074347-001May 28, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke DavisCHOLYBARcholestyramineBAR, CHEWABLE;ORAL071621-001May 26, 1988► Subscribe► Subscribe
Parke DavisCHOLYBARcholestyramineBAR, CHEWABLE;ORAL071739-001May 26, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Johnson and Johnson
Healthtrust
McKesson
Cerilliant
Deloitte
Dow
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot